HemaSphere (Jun 2022)
P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON
- M. Delforge,
- S. Z. Usmani,
- N. W. van de Donk,
- A. L. Garfall,
- P. Moreau,
- A. Oriol,
- A. K. Nooka,
- L. Rosinol,
- N. Bahlis,
- P. Rodriguez-Otero,
- T. Martin,
- J. Diels,
- S. Van Sanden,
- L. Pei,
- E. Ammann,
- R. Kobos,
- M. Slavcev,
- J. Smit,
- A. Londhe,
- A. Krishnan
Affiliations
- M. Delforge
- 1 University of Leuven, Leuven, Belgium
- S. Z. Usmani
- 2 Memorial Sloan Kettering Cancer Center, New York, NY, United States of America
- N. W. van de Donk
- 3 Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
- A. L. Garfall
- 4 Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States of America
- P. Moreau
- 5 University Hospital Hôtel-Dieu, Nantes, France
- A. Oriol
- 6 Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
- A. K. Nooka
- 7 Winship Cancer Institute, Emory University, Atlanta, GA, United States of America
- L. Rosinol
- 8 Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Spain
- N. Bahlis
- 9 Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
- P. Rodriguez-Otero
- 10 Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain
- T. Martin
- 11 University of California, San Francisco, San Francisco, CA, United States of America
- J. Diels
- 12 Janssen Pharmaceutica NV, Beerse, Belgium
- S. Van Sanden
- 12 Janssen Pharmaceutica NV, Beerse, Belgium
- L. Pei
- 13 Janssen Research & Development
- E. Ammann
- 14 Janssen Global Services, Raritan, NJ
- R. Kobos
- 13 Janssen Research & Development
- M. Slavcev
- 14 Janssen Global Services, Raritan, NJ
- J. Smit
- 15 Janssen Research & Development, Spring House, PA
- A. Londhe
- 16 Janssen Research & Development, Titusville, NJ
- A. Krishnan
- 17 City of Hope Comprehensive Cancer Center, Duarte, CA, United States of America
- DOI
- https://doi.org/10.1097/01.HS9.0000846464.96684.8e
- Journal volume & issue
-
Vol. 6
pp. 789 – 790
Abstract
No abstracts available.